Analysis and data insight - Articles - Page 135

Health professional pointing stethoscope at Clinical Trial words, icons

As COVID-19 efforts subside, clinical news down by 12%

May 31, 2022

About 56% of the clinical data recorded by BioWorld in 2022 target therapies for oncology, as well as infectious and neurological diseases, but news on COVID-19 efforts continue to dwindle compared with last year.

Biggest gainers and losers for the week of May 23-27, 2022

May 27, 2022

The top 10 biopharma stock gainers and losers for the week.

Med-tech financings at lowest point in four years

May 27, 2022

By Karen Carey

Financings of med-tech companies are at their lowest levels in four years, with amounts collected falling 43.5% below the next highest year.

Med-tech gainers and losers for May 23-27, 2022

May 27, 2022

The top 10 med-tech stock gainers and losers for the week.

Biopharma money raised: Jan. 1-May 26, 2022

May 27, 2022

Year-to-date money raised in public, private and other financings of biopharma companies.

Money raised by biopharma: 2022 vs. 2021 vs. 2020 vs. 2019

May 27, 2022

Total raised in public, private and other financings of biopharma companies, comparing 2022 vs. 2021 vs. 2020 vs. 2019.

Biopharma grant and nonprofit deal values plunge

May 24, 2022

By Karen Carey

As the COVID-19 pandemic continues to wind down, the value of biopharma company deals with nonprofit and government entities, as well as grants, are down nearly 64%. Through mid-May 2022, BioWorld has tracked 309 bio/nonprofit deals worth $1.12 billion, and a total of 129 grants valued at $505.85 million.